Ceremedy is a Copenhagen-based biotech company focused on drug discovery for the treatment of CNS disorders. The company was founded in 2018 as a spin-off from the University of Copenhagen.
Ceremedy’s team strives to develop new treatments for CNS disorders by targeting an important brain protein with a broad range of implications for treating CNS disorders. Backed with medicinal chemistry, pharmacology and neuroscience experience, we aim to facilitate the full process from idea to drug candidate.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Ole Maaløes Vej 3, Copenhagen,capital Region Of Denmark 2200,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ceremedy.com
- HQ
- Copenhagen, Capital Region of Denmark
Ceremedy Aps Questions
Ceremedy Aps's website is http://www.ceremedy.com
Ceremedy Aps's LinkedIn profile is https://dk.linkedin.com/company/ceremedy
Ceremedy Aps has
8 employees.
View email and phone details for 8
employees at Ceremedy Aps.
Ceremedy Aps's industry is
Biotechnology Research
Ceremedy Aps's top competitors are
Fluoguide A/s (Nasdaq: Fluo),
Symphogen,
Ascendis Pharma,
Zealand Pharma,
Bioinnovation Institute,
Zyneyro,
Medivir Ab,
Alk,
Triptobio,
Minerva Imaging.
Ceremedy Aps's categories are Biotechnology Research
Ceremedy Aps's founding year is 2018
